RostaQuo S.p.A.

Country

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations

Phase 2

Conditions: Essential Hypertension

Interventions: Drug: Rostafuroxin
Drug: Losartan

First Posted Date: 2011-03-22

Last Posted Date: 2011-03-23

Lead Sponsor: RostaQuo S.p.A.

Target Recruit Count: 240

Registration Number: NCT01320397

Locations: 🇮🇪
Portiuncula Hospital, Ballinasloe, Galway, Ireland
🇮🇹
Ospedale "Santa Maria", Borgo Val di Taro, Parma, Italy
🇮🇪
James Connolly memorial Hospital, Dublin, Ireland

and more 23 locations

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy